Literature DB >> 24637778

Utility of dissociated intrinsic hand muscle atrophy in the diagnosis of amyotrophic lateral sclerosis.

Parvathi Menon1, Steve Vucic2.   

Abstract

The split hand phenomenon refers to predominant wasting of thenar muscles and is an early and specific feature of amyotrophic lateral sclerosis (ALS). A novel split hand index (SI) was developed to quantify the split hand phenomenon, and its diagnostic utility was assessed in ALS patients. The split hand index was derived by dividing the product of the compound muscle action potential (CMAP) amplitude recorded over the abductor pollicis brevis and first dorsal interosseous muscles by the CMAP amplitude recorded over the abductor digiti minimi muscle. In order to assess the diagnostic utility of the split hand index, ALS patients were prospectively assessed and their results were compared to neuromuscular disorder patients. The split hand index was significantly reduced in ALS when compared to neuromuscular disorder patients (P<0.0001). Limb-onset ALS patients exhibited the greatest reduction in the split hand index, and a value of 5.2 or less reliably differentiated ALS from other neuromuscular disorders. Consequently, the split hand index appears to be a novel diagnostic biomarker for ALS, perhaps facilitating an earlier diagnosis.

Entities:  

Mesh:

Year:  2014        PMID: 24637778      PMCID: PMC4123526          DOI: 10.3791/51056

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  20 in total

1.  The "split hand syndrome".

Authors:  A J Wilbourn
Journal:  Muscle Nerve       Date:  2000-01       Impact factor: 3.217

2.  Dissociated small hand muscle involvement in amyotrophic lateral sclerosis detected by motor unit number estimates.

Authors:  S Kuwabara; K Mizobuchi; K Ogawara; T Hattori
Journal:  Muscle Nerve       Date:  1999-07       Impact factor: 3.217

3.  ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.

Authors:  A Chiò
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

4.  The split hand in ALS has a cortical basis.

Authors:  M Weber; A Eisen; H Stewart; N Hirota
Journal:  J Neurol Sci       Date:  2000-11-01       Impact factor: 3.181

Review 5.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

6.  Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

Authors:  F Kimura; C Fujimura; S Ishida; H Nakajima; D Furutama; H Uehara; K Shinoda; M Sugino; T Hanafusa
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

7.  Utility of magnetic resonance imaging in diagnosing ulnar neuropathy at the elbow.

Authors:  S Vucic; D J Cordato; C Yiannikas; R S Schwartz; R C Shnier
Journal:  Clin Neurophysiol       Date:  2006-02-14       Impact factor: 3.708

8.  Split-hand index for the diagnosis of amyotrophic lateral sclerosis.

Authors:  Parvathi Menon; Matthew C Kiernan; Con Yiannikas; Jill Stroud; Steve Vucic
Journal:  Clin Neurophysiol       Date:  2012-09-25       Impact factor: 3.708

9.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

10.  Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O M Hardiman
Journal:  Arch Neurol       Date:  2000-08
View more
  1 in total

1.  Neurophysiological Differences between Flail Arm Syndrome and Amyotrophic Lateral Sclerosis.

Authors:  Hecheng Yang; Mingsheng Liu; Xiaoguang Li; Bo Cui; Jia Fang; Liying Cui
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.